tiprankstipranks
Trending News
More News >
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market

Nautilus Biotechnolgy (NAUT) Income Statement

Compare
167 Followers

Nautilus Biotechnolgy Income Statement

Last quarter (Q3 2025), Nautilus Biotechnolgy's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Nautilus Biotechnolgy's net income was $-13.57M. See Nautilus Biotechnolgy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.35M$ -5.71M$ -3.42M$ -2.84M$ -2.35M
Operating Expenses
$ 75.12M$ 70.45M$ 60.20M$ 47.66M$ 13.40M
Depreciation and Amortization
$ 6.35M$ 1.85M$ 3.42M$ 2.84M$ 2.35M
EBITDA
$ -64.43M$ -74.30M$ -54.51M$ -47.47M$ -13.27M
Operating Income
$ -81.48M$ -76.15M$ -63.62M$ -50.50M$ -15.74M
Other Income/Expenses
$ 10.70M$ 12.48M$ 5.69M$ 183.00K$ 125.00K
Pretax Income
$ -70.78M$ -63.67M$ -57.92M$ -50.31M$ -15.62M
Net Income
$ -70.78M$ -63.67M$ -57.92M$ -50.31M$ -15.62M
Per Share Metrics
Basic EPS
$ -0.56$ -0.51$ -0.46$ -0.60$ -0.47
Diluted EPS
$ -0.56$ -0.51$ -0.46$ -0.60$ -0.47
Weighted Average Shares Outstanding
125.43M 124.92M 124.59M 84.46M 33.07M
Weighted Average Shares Outstanding (Diluted)
125.43M 124.92M 124.59M 84.46M 33.07M
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History